Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
Sponsored
BIB
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
68.77
Seasonality Move:
2.56%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.98 | Buy |
20-day SMA: | 66.07 | Buy |
50-day SMA: | 65.28 | Buy |
200-day SMA: | 58.39 | Buy |
8-day EMA: | 66.31 | Buy |
20-day EMA: | 65.73 | Buy |
50-day EMA: | 64.37 | Buy |
200-day EMA: | 59.12 | Buy |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.56 | Buy |
Relative Strength Index (14 RSI): | 55.48 | Buy |
Chaikin Money Flow: | -8699 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.16 - 67.46) | Buy |
Bollinger Bands (100): | (56.44 - 65.98) | Buy |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
- ProShares Ultra Nasdaq Biotechnology share price is 66.68 while BIB 8-day simple moving average is 65.98, which is a Buy signal.
- The stock price of BIB is 66.68 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 66.07, which makes it a Buy.
- ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 65.28 while BIB share price is 66.68, making it a Buy technically.
- BIB stock price is 66.68 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 58.39, creating a Buy signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
44
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a Sell
The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $66.68. The Score for BIB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
66.68
Share Volume:
9.5K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
40.10
Sell
44
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?
The ProShares Ultra Nasdaq Biotechnology stock price is 66.68 USD today. -
Will BIB stock go up or go down?
ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators -
Is ProShares Ultra Nasdaq Biotechnology overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
- ProShares Ultra Nasdaq Biotechnology share price is 66.68 while BIB 8-day exponential moving average is 66.31, which is a Buy signal.
- The stock price of BIB is 66.68 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 65.73, which makes it a Buy.
- ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 64.37 while BIB share price is 66.68, making it a Buy technically.
- BIB stock price is 66.68 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 59.12, creating a Buy signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
- BIB Moving Average Covergence Divergence (MACD) indicator is 0.56, suggesting ProShares Ultra Nasdaq Biotechnology is a Buy
- ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 55.48, which suggest ProShares Ultra Nasdaq Biotechnology is overbought
- The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (64.16 - 67.46), which suggest ProShares Ultra Nasdaq Biotechnology is a Buy
- The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (56.44 - 65.98), which suggest ProShares Ultra Nasdaq Biotechnology is a Buy
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.